Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC29H44N2O8 |
InChIKeyVFJOOSVDHSUNKR-DQJDZTSCSA-N |
CAS Registry199333-57-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CZ | 03 Oct 2024 |